Status
Conditions
Study type
Funder types
Identifiers
About
This study aims to develop advanced artificial intelligence (AI) models that predict neonatal risks and complications based on historical multimodal health data, including ultrasound and MRI scans. The objective is to empower clinicians and provide clear, compassionate support for families navigating complex prenatal diagnoses.
Full description
The FetalFirst study employs observational, retrospective analysis utilizing DenseNet121 neural networks. It analyzes de-identified retrospective data comprising ultrasound images, MRI scans, and clinical documentation from existing medical records. This research has received ethical approval from Wales Research Ethics Committee (REC ref: 25/WA/0168, IRAS ID: 358793). Outcomes from this study are expected to significantly enhance clinical intervention strategies, offering healthcare professionals robust tools for earlier detection and improved management of congenital anomalies and neonatal risks. Additionally, the insights gained will provide critical support to parents facing high-risk pregnancies, assisting them in making informed decisions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
50,000 participants in 1 patient group
Loading...
Central trial contact
Nawal (Nina) Abide, EMBA, MA, BA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal